Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease-Reference-Cited by-同舟云学术

Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease

Published:2021-10-26 Issue:1 Volume:38 Page:27-34
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Coleman Craig I.¹²^ORCID,Kharat Akshay A.³^ORCID,Bookhart Brahim³,Baker William L.¹²^ORCID

Affiliation:

1. Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA

2. Evidence-based Practice Center, Hartford Hospital, Hartford, Connecticut, USA

3. Real World Value and Evidence, Janssen Scientific Affairs LLC, Titusville, New Jersey, USA

Funder

Janssen Scientific Affairs

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1991294

Reference24 articles.

1. Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis

2. Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors

3. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

4. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-catheterization complications in diabetic patients with myocardial infarction;World Family Medicine Journal /Middle East Journal of Family Medicine;2022-11